Chloroprocaine 1% Injectable Solution — Competitive Intelligence Brief

Chloroprocaine 1% Injectable Solution (Chloroprocaine 1% Injectable Solution) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (ester). Area: Anesthesia.

marketed Local anesthetic (ester) Voltage-gated sodium channels Anesthesia Small molecule

Target snapshot

Chloroprocaine 1% Injectable Solution (Chloroprocaine 1% Injectable Solution) — Sintetica SA. Chloroprocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of nerve impulses.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Chloroprocaine 1% Injectable Solution TARGET	Chloroprocaine 1% Injectable Solution	Sintetica SA	marketed	Local anesthetic (ester)	Voltage-gated sodium channels
lidocaine and sufentanil	lidocaine and sufentanil	RenJi Hospital	marketed	Local anesthetic and opioid analgesic combination	Voltage-gated sodium channels (lidocaine); mu opioid receptor (sufentanil)
Low-Dose Lidocaine	Low-Dose Lidocaine	The Methodist Hospital Research Institute	marketed	Local anesthetic / sodium channel blocker	Voltage-gated sodium channels
Lidocaïne	Lidocaïne	University Hospital, Angers	marketed	Local anesthetic	Voltage-gated sodium channels
Hydrocortisone acetate and lidocaine hydrochloride	Hydrocortisone acetate and lidocaine hydrochloride	Citius Pharmaceuticals, Inc.	marketed	Topical corticosteroid and local anesthetic combination	Glucocorticoid receptor (hydrocortisone); voltage-gated sodium channels (lidocaine)
Lidocaine alone	Lidocaine alone	TriHealth Inc.	marketed	Local anesthetic	Voltage-gated sodium channels
Naropeine (Ropivacaine)	Naropeine (Ropivacaine)	Nantes University Hospital	marketed	Local anesthetic (amide)	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (ester) class)

1. Sintetica SA · 4 drugs in this class
2. Centre Hospitalier Universitaire Saint Pierre · 1 drug in this class
3. Nova Scotia Health Authority · 1 drug in this class
4. American Genomics, LLC · 1 drug in this class
5. University of Miami · 1 drug in this class
6. Wenzhou Medical University · 1 drug in this class
7. Oregon Health and Science University · 1 drug in this class